Back

Galectin-3 as a risk factor recurrence of atrial fibrillation in patients with metabolic syndrome

17 March 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial Fibrillation - Treatment Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2019

About the speaker

Photo
Assistant Professor Valery Ionin

Saint Petersburg First Pavlov State Medical University, Saint Petersburg (Russian Federation)

47 More presentations in this session

Presentation thumbnail
Doctor M. Tanaka (Kobe, JP)
Abstract
Presentation thumbnail
Doctor A. Kobori (Kobe, JP)
Abstract
Presentation thumbnail
Doctor Y. Sasaki (Kobe, JP)
Abstract
Presentation thumbnail
Doctor J. Morita (Sapporo, JP)
Abstract
Presentation thumbnail
Doctor G. Mugnai (Verona, IT)

Access the full session

Session thumbnail
Poster session 1 - Atrial Fibrillation - Treatment

The Event

Event poster

EHRA 2019

17 March 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Galectin-3 predicts the risk of ventricular tachycardia in ischemic heart failure patients with implantable cardioverter-defibrillator
30 June 2021
thumbnail
Congress Presentation
Structural remodeling and left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome
30 August 2025
thumbnail
Webinar
ACVC Biomarker Talk Series - Biomarkers in atrial fibrillation
24 November 2021
thumbnail
Congress Presentation
Value of cardiac 123I-mIBG scintigraphy in prognosis of catheter ablation outcome in patients with atrial fibrillation
9 May 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources